Kimberly-Clark bets $40 billion on Kenvue
Digest more
Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...
Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...
Clark said on Monday it plans to acquire Band-Aid maker Kenvue, even as the latter company faces thousands of lawsuits ...
Kenvue (KVUE) reported a net profit margin of 9.4%, up from 7.3% last year. One-year earnings growth reached 26.3%, and the ...
The major stock indexes were mixed on Monday, at the outset of another busy week of quarterly earnings reports and the release of key private sector employment data.
D.E. Shaw, one of the Tylenol-maker’s largest shareholders, stood to lose over $200 million but is now expected to break even ...
Kenvue stock has struggled this year, but an acquisition offer is giving investors hope leading up to this week's earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback